Literature DB >> 27342951

It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence.

C C Kirwan1, C E Coles2, J Bliss3.   

Abstract

Entities:  

Year:  2016        PMID： 27342951     DOI： 10.1016/j.clon.2016.06.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  16 in total

1.  Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial?

Authors:  Anna M Kirby
Journal:  Br J Radiol       Date:  2018-03-23       Impact factor: 3.039

Review 2.  De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients.

Authors:  Pierfrancesco Franco; Giuseppe Carlo Iorio; Sara Bartoncini; Mario Airoldi; Corrado De Sanctis; Isabella Castellano; Umberto Ricardi
Journal:  Med Oncol       Date:  2018-04-03       Impact factor: 3.064

Review 3.  De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

Authors:  E Shelley Hwang; Lawrence Solin
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

4.  The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up.

Authors:  I S Bhattacharya; J P Morden; C Griffin; C Snowdon; R Brannan; J M Bliss; L Kilburn
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-10-26       Impact factor: 4.126

5.  Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial.

Authors:  Jean-Michel Hannoun-Levi; Emmanuel Chamorey; Rabia Boulahssass; Csaba Polgar; Vratislav Strnad
Journal:  Clin Transl Radiat Oncol       Date:  2021-04-22

Review 6.  Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology).

Authors:  Isabella Palumbo; Simona Borghesi; Fabiana Gregucci; Sara Falivene; Antonella Fontana; Cynthia Aristei; Antonella Ciabattoni
Journal:  J Geriatr Oncol       Date:  2021-05-18       Impact factor: 3.599

7.  Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.

Authors:  Martin Sjöström; Johan Staaf; Patrik Edén; Fredrik Wärnberg; Jonas Bergh; Per Malmström; Mårten Fernö; Emma Niméus; Irma Fredriksson
Journal:  Breast Cancer Res       Date:  2018-07-04       Impact factor: 6.466

8.  Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design.

Authors:  Indrani S Bhattacharya; Joanne S Haviland; Charlotte E Coles; Judith M Bliss; Lesley Turner; Hilary Stobart; Ada Balasopoulou; Liba Stones; Anna M Kirby; Cliona C Kirwan
Journal:  Trials       Date:  2021-06-14       Impact factor: 2.279

Review 9.  Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.

Authors:  Corey Speers; Lori J Pierce
Journal:  Int J Breast Cancer       Date:  2017-11-26

Review 10.  Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?

Authors:  I S Bhattacharya; A M Kirby; J M Bliss; C E Coles
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-01-10       Impact factor: 4.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.